May 13, 2025NeuroOne Medical Technologies Corporation misses on earnings expectations. Reported EPS is $-72.98221 EPS, expectations were $-0.09. Operator: Good day, ladies and gentlemen. Welcome to ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath©, a novel, FDA-cleared ...

Between 2022 and 2027, leading data and analytics company GlobalData forecasts show cybersecurity spending by healthcare ...

It is not a requirement for marketing such devices that the name of the device has been proved to correspond to what is ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

Welcome to the second-quarter of fiscal year 2025 financial results conference call for NeuroOne Medical Technologies Corporation. Today's call will be conducted by the company's Chief Executive ...

A Boston Duck Tours guide is back to work after a groundbreaking aortic aneurysm repair at Tufts Medical Center, thanks to a newly FDA-approved device.

FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and Intern ...

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the ...

The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite. Plan to ...